SPOC1-Mediated Antiviral Host Cell Response Is Antagonized Early in Human Adenovirus Type 5 Infection


Little is known about immediate phases after viral infection and how an incoming viral genome complex counteracts host cell defenses, before the start of viral gene expression. Adenovirus (Ad) serves as an ideal model, since entry and onset of gene expression are rapid and highly efficient, and mechanisms used 24–48 hours post infection to counteract host antiviral and DNA repair factors (e.g. p53, Mre11, Daxx) are well studied. Here, we identify an even earlier host cell target for Ad, the chromatin-associated factor and epigenetic reader, SPOC1, recently found recruited to double strand breaks, and playing a role in DNA damage response. SPOC1 co-localized with viral replication centers in the host cell nucleus, interacted with Ad DNA, and repressed viral gene expression at the transcriptional level. We discovered that this SPOC1-mediated restriction imposed upon Ad growth is relieved by its functional association with the Ad major core protein pVII that enters with the viral genome, followed by E1B-55K/E4orf6-dependent proteasomal degradation of SPOC1. Mimicking removal of SPOC1 in the cell, knock down of this cellular restriction factor using RNAi techniques resulted in significantly increased Ad replication, including enhanced viral gene expression. However, depletion of SPOC1 also reduced the efficiency of E1B-55K transcriptional repression of cellular promoters, with possible implications for viral transformation. Intriguingly, not exclusive to Ad infection, other human pathogenic viruses (HSV-1, HSV-2, HIV-1, and HCV) also depleted SPOC1 in infected cells. Our findings provide a general model for how pathogenic human viruses antagonize intrinsic SPOC1-mediated antiviral responses in their host cells. A better understanding of viral entry and early restrictive functions in host cells should provide new perspectives for developing antiviral agents and therapies. Conversely, for Ad vectors used in gene therapy, counteracting mechanisms eradicating incoming viral DNA would increase Ad vector efficacy and safety for the patient.


Vyšlo v časopise: SPOC1-Mediated Antiviral Host Cell Response Is Antagonized Early in Human Adenovirus Type 5 Infection. PLoS Pathog 9(11): e32767. doi:10.1371/journal.ppat.1003775
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003775

Souhrn

Little is known about immediate phases after viral infection and how an incoming viral genome complex counteracts host cell defenses, before the start of viral gene expression. Adenovirus (Ad) serves as an ideal model, since entry and onset of gene expression are rapid and highly efficient, and mechanisms used 24–48 hours post infection to counteract host antiviral and DNA repair factors (e.g. p53, Mre11, Daxx) are well studied. Here, we identify an even earlier host cell target for Ad, the chromatin-associated factor and epigenetic reader, SPOC1, recently found recruited to double strand breaks, and playing a role in DNA damage response. SPOC1 co-localized with viral replication centers in the host cell nucleus, interacted with Ad DNA, and repressed viral gene expression at the transcriptional level. We discovered that this SPOC1-mediated restriction imposed upon Ad growth is relieved by its functional association with the Ad major core protein pVII that enters with the viral genome, followed by E1B-55K/E4orf6-dependent proteasomal degradation of SPOC1. Mimicking removal of SPOC1 in the cell, knock down of this cellular restriction factor using RNAi techniques resulted in significantly increased Ad replication, including enhanced viral gene expression. However, depletion of SPOC1 also reduced the efficiency of E1B-55K transcriptional repression of cellular promoters, with possible implications for viral transformation. Intriguingly, not exclusive to Ad infection, other human pathogenic viruses (HSV-1, HSV-2, HIV-1, and HCV) also depleted SPOC1 in infected cells. Our findings provide a general model for how pathogenic human viruses antagonize intrinsic SPOC1-mediated antiviral responses in their host cells. A better understanding of viral entry and early restrictive functions in host cells should provide new perspectives for developing antiviral agents and therapies. Conversely, for Ad vectors used in gene therapy, counteracting mechanisms eradicating incoming viral DNA would increase Ad vector efficacy and safety for the patient.


Zdroje

1. BlanchetteP, BrantonPE (2009) Manipulation of the ubiquitin-proteasome pathway by small DNA tumor viruses. Virology 384: 317–323.

2. SchreinerS, MartinezR, GroitlP, RayneF, VaillantR, et al. (2012) Transcriptional activation of the adenoviral genome is mediated by capsid protein. PLoS Pathog 8: e1002549.

3. BerkAJ (2005) Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24: 7673–7685.

4. BerscheminskiJ, GroitlP, DobnerT, WimmerP, SchreinerS (2012) The Adenoviral Oncogene E1A-13S Interacts with a Specific Isoform of the Tumor Suppressor PML To Enhance Viral Transcription. J Virol 87: 965–977.

5. BlackfordAN, GrandRJ (2009) Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation. J Virol 83: 4000–4012.

6. SchreinerS, WimmerP, DobnerT (2012) Adenovirus degradation of cellular proteins. Future Microbiol 7(2): 211–225.

7. HaradaJN, ShevchenkoA, PallasDC, BerkAJ (2002) Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J Virol 76: 9194–9206.

8. BlanchetteP, ChengCY, YanQ, KetnerG, OrnellesDA, et al. (2004) Both BC-box motifs of adenovirus protein E4orf6 are required to assemble an E3 ligase complex that degrades p53. Mol Cell Biol 24: 9619–9629.

9. QueridoE, BlanchetteP, YanQ, KamuraT, MorrisonM, et al. (2001) Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev 15: 3104–3117.

10. GuptaA, JhaS, EngelDA, OrnellesDA, DuttaA (2012) Tip60 degradation by adenovirus relieves transcriptional repression of viral transcriptional activator EIA. Oncogene 32: 5017–25.

11. BlackfordAN, PatelRN, ForresterNA, TheilK, GroitlP, et al. (2010) Adenovirus 12 E4orf6 inhibits ATR activation by promoting TOPBP1 degradation. Proc Natl Acad Sci U S A 107: 12251–12256.

12. SchreinerS, WimmerP, SirmaH, EverettRD, BlanchetteP, et al. (2010) Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells. J Virol 84: 7029–7038.

13. SchreinerS, BürckC, GlassM, GroitlP, WimmerP, et al. (2013) Control of Human Adenovirus type 5 (Ad5) gene expression by cellular Daxx/ATRX chromatin-associated complexes. Nucleic Acids Res 41: 3532–50.

14. AraujoFD, StrackerTH, CarsonCT, LeeDV, WeitzmanMD (2005) Adenovirus type 5 E4orf3 protein targets the Mre11 complex to cytoplasmic aggresomes. J Virol 79: 11382–11391.

15. EvansJD, HearingP (2003) Distinct Roles of the Adenovirus E4 ORF3 Protein in Viral DNA Replication and Inhibition of Genome Concatenation. J Virol 77: 5295–5304.

16. EvansJD, HearingP (2005) Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication. J Virol 79: 6207–6215.

17. StrackerTH, CarsonCT, WeitzmanMD (2002) Adenovirus oncoproteins inactivate the Mre11 Rad50 NBS1 DNA repair complex. Nature 418: 348–352.

18. StrackerTH, LeeDV, CarsonCT, AraujoFD, OrnellesDA, et al. (2005) Serotype-specific reorganization of the Mre11 complex by adenoviral E4orf3 proteins. J Virol 79: 6664–5573.

19. MundA, SchubertT, StaegeH, KinkleyS, ReumannK, et al. (2012) SPOC1 Modulates DNA Repair by Regulating Key Determinants of Chromatin Compaction and DNA Damage Response. Nucleic Acids Res 40: 11363–11379.

20. KinkleyS, StaegeH, MohrmannG, RohalyG, SchaubT, et al. (2009) SPOC1: a novel PHD-containing protein modulating chromatin structure and mitotic chromosome condensation. J Cell Sci 122: 2946–2956.

21. ImyanitovEN, BirrellGW, FilippovichI, SorokinaN, ArnoldJ, et al. (1999) Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target. Oncogene 18: 4640–4642.

22. RagnarssonG, EiriksdottirG, JohannsdottirJT, JonassonJG, EgilssonV, et al. (1999) Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Br J Cancer 79: 1468–1474.

23. MohrmannG, HengstlerJG, HofmannTG, EndeleSU, LeeB, et al. (2005) SPOC1, a novel PHD-finger protein: association with residual disease and survival in ovarian cancer. Int J Cancer 116: 547–554.

24. BordleinA, ScherthanH, NelkenbrecherC, MolterT, BoslMR, et al. (2011) SPOC1 (PHF13) is required for spermatogonial stem cell differentiation and sustained spermatogenesis. J Cell Sci 124: 3137–3148.

25. ChiP, AllisCD, WangGG (2010) Covalent histone modifications–miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 10: 457–469.

26. BakerA, RohlederKJ, HanakahiLA, KetnerG (2007) Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation. J Virol 81: 7034–7040.

27. OrazioNI, NaegerCM, KarlsederJ, WeitzmanMD (2011) The adenovirus E1b55K/E4orf6 complex induces degradation of the Bloom helicase during infection. J Virol 85: 1887–1892.

28. ZantemaA, FransenJA, DavisOA, RamaekersFC, VooijsGP, et al. (1985) Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies. Virology 142: 44–58.

29. ZantemaA, SchrierPI, DavisOA, van LaarT, VaessenRT, et al. (1985) Adenovirus serotype determines association and localization of the large E1B tumor antigen with cellular tumor antigen p53 in transformed cells. Mol Cell Biol 5: 3084–3091.

30. GoodrumFD, ShenkT, OrnellesDA (1996) Adenovirus early region 4 34-kilodalton protein directs the nuclear localization of the early region 1B 55-kilodalton protein in primate cells. J Virol 70: 6323–6335.

31. KönigC, RothJ, DobbelsteinM (1999) Adenovirus type 5 E4orf3 protein relieves p53 inhibition by E1B-55-kilodalton protein. J Virol 73: 2253–2262.

32. KrätzerF, RosoriusO, HegerP, HirschmannN, DobnerT, et al. (2000) The adenovirus type 5 E1B-55k oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2. Oncogene 19: 850–857.

33. WienzekS, RothJ, DobbelsteinM (2000) E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53. J Virol 74: 193–202.

34. BlanchetteP, WimmerP, DallaireF, ChengCY, BrantonPE (2013) Aggresome Formation by the Adenoviral Protein E1B55K Is Not Conserved among Adenovirus Species and Is Not Required for Efficient Degradation of Nuclear Substrates. J Virol 87: 4872–4881.

35. LeeTW, BlairGE, MatthewsDA (2003) Adenovirus core protein VII contains distinct sequences that mediate targeting to the nucleus and nucleolus, and colocalization with human chromosomes. J Gen Virol 84: 3423–3428.

36. KarenKA, HearingP (2011) Adenovirus core protein VII protects the viral genome from a DNA damage response at early times after infection. J Virol 85: 4135–4142.

37. ChenJ, MorralN, EngelDA (2007) Transcription releases protein VII from adenovirus chromatin. Virology 369: 411–422.

38. XueY, JohnsonJS, OrnellesDA, LiebermanJ, EngelDA (2005) Adenovirus protein VII functions throughout early phase and interacts with cellular proteins SET and pp32. J Virol 79: 2474–2483.

39. WalkiewiczMP, MorralN, EngelDA (2009) Accurate single-day titration of adenovirus vectors based on equivalence of protein VII nuclear dots and infectious particles. J Virol Methods 159: 251–258.

40. MatsumotoK, NagataK, UiM, HanaokaF (1993) Template activating factor I, a novel host factor required to stimulate the adenovirus core DNA replication. J Biol Chem 268: 10582–10587.

41. OkuwakiM, NagataK (1998) Template activating factor-I remodels the chromatin structure and stimulates transcription from the chromatin template. J Biol Chem 273: 34511–34518.

42. KomatsuT, HarukiH, NagataK (2011) Cellular and viral chromatin proteins are positive factors in the regulation of adenovirus gene expression. Nucleic Acids Res 39: 889–901.

43. WodrichH, CassanyA, D'AngeloMA, GuanT, NemerowG, et al. (2006) Adenovirus core protein pVII is translocated into the nucleus by multiple import receptor pathways. J Virol 80: 9608–9618.

44. BrownDT, WestphalM, BurlinghamBT, WinterhoffU, DoerflerW (1975) Structure and composition of the adenovirus type 2 core. J Virol 16: 366–387.

45. van OostrumJ, BurnettRM (1985) Molecular composition of the adenovirus type 2 virion. J Virol 56: 439–448.

46. VaydaME, FlintSJ (1987) Isolation and characterization of adenovirus core nucleoprotein subunits. J Virol 61: 3335–3339.

47. SergeantA, TiggesMA, RaskasHJ (1979) Nucleosome-like structural subunits of intranuclear parental adenovirus type 2 DNA. J Virol 29: 888–898.

48. MaisonC, AlmouzniG (2004) HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol 5: 296–304.

49. GronerAC, MeylanS, CiuffiA, ZanggerN, AmbrosiniG, et al. (2010) KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading. PLoS Genet 6: e1000869.

50. SunY, JiangX, XuY, AyrapetovMK, MoreauLA, et al. (2009) Histone H3 methylation links DNA damage detection to activation of the tumour suppressor Tip60. Nat Cell Biol 11: 1376–1382.

51. FritschL, RobinP, MathieuJR, SouidiM, HinauxH, et al. (2010) A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Mol Cell 37: 46–56.

52. GrahamFL, SmileyJ, RusselWC, NairnR (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59–72.

53. MitsudomiT, SteinbergSM, NauMM, CarboneD, D'AmicoD, et al. (1992) p53 gene mutations in non-small-lung cell cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7: 171–180.

54. NevelsM, TäuberB, SprussT, WolfH, DobnerT (2001) “Hit-and-run” transformation by adenovirus oncogenes. J Virol 75: 3089–3094.

55. RubenwolfS, SchüttH, NevelsM, WolfH, DobnerT (1997) Structural analysis of the adenovirus type 5 E1B 55-kilodalton-E4orf6 protein complex. J Virol 71: 1115–1123.

56. ChengCY, GilsonT, DallaireF, KetnerG, BrantonPE, et al. The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity. J Virol 85: 765–775.

57. SchreinerS, WimmerP, GroitlP, ChenSY, BlanchetteP, et al. (2011) Adenovirus Type 5 Early Region 1B 55K Oncoprotein-Dependent Degradation of Cellular Factor Daxx Is Required for Efficient Transformation of Primary Rodent Cells. J Virol 85: 8752–8765.

58. ChengCY, GilsonT, WimmerP, SchreinerS, KetnerG, et al. (2013) The role of E1B55K in E4orf6/E1B55K E3 ligase complexes formed by different human adenovirus serotypes. J Virol 87: 6232–45.

59. NevelsM, RubenwolfS, SprussT, WolfH, DobnerT (1997) The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function. Proc Natl Acad Sci USA 94: 1206–1211.

60. GroitlP, DobnerT (2007) Construction of adenovirus type 5 early region 1 and 4 virus mutants. Methods Mol Med 130: 29–39.

61. BlanchetteP, KindsmullerK, GroitlP, DallaireF, SpeisederT, et al. (2008) Control of mRNA export by adenovirus E4orf6 and E1B55K proteins during productive infection requires E4orf6 ubiquitin ligase activity. J Virol 82: 2642–2651.

62. KindsmullerK, GroitlP, HartlB, BlanchetteP, HauberJ, et al. (2007) Intranuclear targeting and nuclear export of the adenovirus E1B-55K protein are regulated by SUMO1 conjugation. Proc Natl Acad Sci U S A 104: 6684–6689.

63. KindsmullerK, SchreinerS, LeinenkugelF, GroitlP, KremmerE, et al. (2009) A 49-kilodalton isoform of the adenovirus type 5 early region 1B 55-kilodalton protein is sufficient to support virus replication. J Virol 83: 9045–9056.

64. WimmerP, SchreinerS, EverettRD, SirmaH, GroitlP, et al. (2010) SUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PML. Oncogene 29: 5511–5522.

65. SarnowP, SullivanCA, LevineAJ (1982) A monoclonal antibody detecting the adenovirus type 5-E1b-58Kd tumor antigen: characterization of the E1b-58Kd tumor antigen in adenovirus-infected and -transformed cells. Virology 120: 510–517.

66. ReichNC, SarnowP, DupreyE, LevineAJ (1983) Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein. Virology 128: 480–484.

67. MartonMJ, BaimSB, OrnellesDA, ShenkT (1990) The adenovirus E4 17-kilodalton protein complexes with the cellular transcription factor E2F, altering its DNA-binding properties and stimulating E1A-independent accumulation of E2 mRNA. J Virol 64: 2345–2359.

68. WodrichH, HenaffD, JammartB, Segura-MoralesC, SeelmeirS, et al. (2010) A capsid-encoded PPxY-motif facilitates adenovirus entry. PLoS Pathog 6: e1000808.

69. ChesebroB, WehrlyK, NishioJ, PerrymanS (1992) Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 66: 6547–6554.

70. VojtesekB, BartekJ, MidgleyCA, LaneDP (1992) An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 151: 237–244.

71. HerrmannF, LeeJ, BedfordMT, FackelmayerFO (2005) Dynamics of human protein arginine methyltransferase 1(PRMT1) in vivo. J Biol Chem 280: 38005–38010.

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2013 Číslo 11
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Eozinofilní granulomatóza s polyangiitidou
nový kurz
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa